Thiamine-responsive congenital lactic acidosis: clinical and biochemical studies

Mitsuo Toyoshima1, Akira Oka, Yoshiko Egi

  • 1Division of Child Neurology, Institute of Neurological Science, Faculty of Medicine, Tottori University, Yonago, Japan.

Pediatric Neurology
|August 10, 2005
PubMed

Insights

Thiamine-responsive congenital lactic acidosis in infants can impair multiple metabolic pathways despite normal pyruvate dehydrogenase complex activity. Early thiamine therapy is crucial to prevent brain damage.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Congenital lactic acidosis is a group of inherited metabolic disorders.
  • Thiamine-responsive congenital lactic acidosis (TR-CLA) presents with elevated lactate and pyruvate levels.
  • The specific metabolic defects in TR-CLA are not fully understood.

Observation:

  • Six infants with TR-CLA and normal in vitro pyruvate dehydrogenase complex activity were studied.
  • Elevated urinary excretion of alpha-ketoglutarate, alpha-ketoadipate, and branched-chain ketoacids was observed.
  • Transport systems (THTR-1, THTR-2) and thiamine pyrophosphokinase (hTPK1) showed no abnormalities.

Findings:

  • Functional impairment of multiple thiamine-dependent enzymes, including pyruvate dehydrogenase complex, alpha-ketoglutarate dehydrogenase complex, and branched-chain amino acid dehydrogenase, was indicated.
  • Despite normal activity of key enzymes in vitro, in vivo metabolic dysfunction was evident.
  • No genetic defects were found in thiamine transport or pyrophosphorylation.

Implications:

  • Early diagnosis and prompt thiamine administration are critical to prevent irreversible neurological damage in infants with TR-CLA.
  • Monitoring lactate and pyruvate levels can aid in optimizing thiamine dosage.
  • Further research into the precise mechanisms of thiamine metabolism in TR-CLA is warranted.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Amino Acid Biosynthetic Pathways01:29

Amino Acid Biosynthetic Pathways

Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which provide...